Lilly Says Its New Injectible Outperforms 3 Popular Diabetes Drugs

clever-pills

Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.

Read more

Posted in Drugs Glucose & Insulin Type II